Evidence map›Paper›PMID 26381398›Full record

ArticlePloS one2015

A Multiplex PCR/LDR Assay for the Simultaneous Identification of Category A Infectious Pathogens: Agents of Viral Hemorrhagic Fever and Variola Virus.

Sanchita Das, Mark S Rundell, Aashiq H Mirza, Maneesh R Pingle, Kristi Shigyo, Aura R Garrison, Jason Paragas, Scott K Smith, Victoria A Olson, Davise H Larone and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Lassa Virus Genetics.Current topics in microbiology and immunology · 2023
    Article
  5. Review
  6. Diagnostic Testing for Crimean-Congo Hemorrhagic Fever.Journal of clinical microbiology · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Biographical Feature: Davise H. Larone, Ph.D.Journal of clinical microbiology · 2018
    Article
  11. Article
  12. Review
  13. Laboratory Diagnosis of Lassa Fever.Journal of clinical microbiology · 2017
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Sanchita DasDepartment of Medicine, Division of Infectious Diseases, Weill Medical College of Cornell University, New York, New York, United States of America.
Mark S RundellDepartment of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.
Aashiq H MirzaDepartment of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.
Maneesh R PingleDepartment of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.
Kristi ShigyoDepartment of Medicine, Division of Infectious Diseases, Weill Medical College of Cornell University, New York, New York, United States of America.
Aura R GarrisonUnited States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America.
Jason ParagasIntegrated Research Facility, Division of Clinical Research, NIAID, NIH, Fort Detrick, Maryland, United States of America.
Scott K SmithPoxvirus Team, Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center of Emerging Zoonotic and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Victoria A OlsonPoxvirus Team, Poxvirus and Rabies Branch, Division of High Consequence Pathogens and Pathology, National Center of Emerging Zoonotic and Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Davise H LaroneDepartment of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America; Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY, United States of America.
Eric D SpitzerDepartment of Pathology, Stony Brook University Medical Center, Stony Brook, New York, United States of America.
Francis BaranyDepartment of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.
Linnie M GolightlyDepartment of Medicine, Division of Infectious Diseases, Weill Medical College of Cornell University, New York, New York, United States of America; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, New York, United States of America.
Cornell University · USCenters for Disease Control and Prevention · USNational Center for Emerging and Zoonotic Infectious Diseases · USOffice of Extramural Research · USStony Brook University Hospital · USUnited States Army Medical Research Institute of Infectious Diseases · US

Funding

Multiplexed Detection of Bioterror AgentsUC1AI062579 · NIAID · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI BARANY, FRANCIS · 2004 to 2004
$4.4M
Global Health Research and Training in malaria and cholera: opportunities for novK24AI110732 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI GOLIGHTLY, LINNIE · 2014 to 2018
$860k
NIAID NIH HHS K24 AI110732NIAID NIH HHS UC1 AI062579NIAID NIH HHS UC1-AI062579
6 · The paper itself

Abstract

CDC designated category A infectious agents pose a major risk to national security and require special action for public health preparedness. They include viruses that cause viral hemorrhagic fever (VHF) syndrome as well as variola virus, the agent of smallpox. VHF is characterized by hemorrhage and fever with multi-organ failure leading to high morbidity and mortality. Smallpox, a prior scourge, has been eradicated for decades, making it a particularly serious threat if released nefariously in the essentially non-immune world population. Early detection of the causative agents, and the ability to distinguish them from other pathogens, is essential to contain outbreaks, implement proper control measures, and prevent morbidity and mortality. We have developed a multiplex detection assay that uses several species-specific PCR primers to generate amplicons from multiple pathogens; these are then targeted in a ligase detection reaction (LDR). The resultant fluorescently-labeled ligation products are detected on a universal array enabling simultaneous identification of the pathogens. The assay was evaluated on 32 different isolates associated with VHF (ebolavirus, marburgvirus, Crimean Congo hemorrhagic fever virus, Lassa fever virus, Rift Valley fever virus, Dengue virus, and Yellow fever virus) as well as variola virus and vaccinia virus (the agent of smallpox and its vaccine strain, respectively). The assay was able to detect all viruses tested, including 8 sequences representative of different variola virus strains from the CDC repository. It does not cross react with other emerging zoonoses such as monkeypox virus or cowpox virus, or six flaviviruses tested (St. Louis encephalitis virus, Murray Valley encephalitis virus, Powassan virus, Tick-borne encephalitis virus, West Nile virus and Japanese encephalitis virus).

Indexed as

Hemorrhagic Fevers, ViralHumansMultiplex Polymerase Chain ReactionSmallpoxVariola virusViruses

Identifiers

PMID26381398
PMCPMC4575071
OpenAlexW2211562931

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.